Sign in

You're signed outSign in or to get full access.

Mark A. Gramz

President, Marcus Theatres at MARCUS
Executive

About Mark A. Gramz

President of Marcus Theatres since October 1, 2022; 53 years with The Marcus Corporation as of FY2024, rising from ticket taker to president, and scheduled to retire March 31, 2026 while serving as advisor thereafter . Holds bachelor’s degrees in economics and business–finance from the University of Wisconsin–Milwaukee; serves on industry boards (Cinema United’s government relations committee and advisory board; regional cinema associations) and received the ShowEast Salah M. Hassanein Humanitarian Award in October 2024 . Under his leadership in Q3 FY2025, Theatres revenue fell 16.6% YoY, operating income declined $9.4M to $12.3M, and adjusted EBITDA decreased 33.4% YoY amid an unfavorable film mix; he guided to improving slate and strong presales into Q4 . Company-level performance anchors executive pay: 2024 Adjusted EBITDA was $102.4M (vs. $108.7M in 2023) and the five-year TSR proxy tracker shows a $100 investment at $69.80 for MCS in 2024, with composite peer group at $132.20 .

Past Roles

OrganizationRoleYearsStrategic Impact
Marcus Theatres (MCS)President2022–present Leads nation’s 4th-largest theatre circuit; drives divisional EBITDA and attendance initiatives
The Marcus CorporationCorporate operational leadership1990–2022 Advanced operations across theatre division; institutional knowledge and execution
Marcus Theatres (Milwaukee market)District Directornot disclosed Regional operations leadership; market performance and guest experience
Marcus TheatresGeneral Managernot disclosed Theatre-level P&L and operations
Marcus TheatresTicket taker (part-time, high school)not disclosed Early frontline experience; career-long operational grounding

External Roles

OrganizationRoleYearsNotes
Cinema UnitedGovernment Relations Committee Member; Advisory Boardnot disclosed Industry advocacy and policy engagement
Wisconsin & Upper Michigan State Cinema Trade AssociationPresidentnot disclosed Regional leadership and industry coordination
ShowEastSalah M. Hassanein Humanitarian Award Recipient2024 Recognition for philanthropic impact

Fixed Compensation

MetricFY2022FY2023FY2024
Base Salary ($)$321,654 $441,308 $461,154
Target Incentive Bonus ($)not disclosednot disclosed$185,017
Actual Incentive Bonus (Non-Equity Incentive Plan Compensation) ($)$90,000 $210,593 $194,000
  • Base salary increase: +4.5% for FY2024; +3.0% for FY2025 .
  • 2024 salary represented ~37% of his total compensation; bonus targeted to divisional metrics + individual goals .

Performance Compensation

Annual Incentive Plan – FY2024 (Division: Marcus Theatres)

ComponentMetricWeightingTargetActualPayout
FinancialTheatres Adjusted EBITDA50% not disclosedAbove Target 108.0% (Financial Component)
FinancialContribution Margin %30% not disclosedBelow Target 108.0% (component total)
FinancialAdmissions Revenue Growth vs North America10% not disclosedBelow Target 108.0% (component total)
FinancialAttendance Growth vs North America10% not disclosedAbove Target 108.0% (component total)
IndividualDiscretionary performance30% of total target not disclosedAchieved Included in $194,000 earned
  • Total FY2024 incentive bonus earned: $194,000 .
  • FY2025 divisional metrics remain consistent with FY2024 constructs (70% financial; 30% individual) .

Long-Term Incentive Awards – Structure and Grants

ElementStructure / Performance MetricMeasurement PeriodPayout ScaleVesting
Performance Stock Units (PSUs)75% ROIC percentile vs Russell 2000; 25% Adjusted EBITDA growth percentile vs Russell 2000 FY2024–FY2026 25% at 25th pct; 100% at 50th; 150% at 75th Per plan; earned based on performance
Performance CashSame metrics as PSUs; ROIC 75% weight; Adjusted EBITDA growth 25% FY2024–FY2026 25%/100%/150% at 25th/50th/75th percentiles Paid post-period upon achievement
Restricted StockTime-based; 50% at 2nd anniversary; 100% at 3rd anniversary (2024+ grants) n/an/a50% at year 2; 100% at year 3
Stock OptionsNo options granted beginning FY2024; legacy options with 10-year terms remain outstanding n/an/aLegacy schedules (various)

Grants (Dollar Values are grant-date fair value; share counts at target for PSUs):

  • FY2024: PSUs 8,200 ($121,688); Restricted Stock 16,400 ($243,376); Performance Cash Target $242,000 .
  • FY2025: PSUs 5,700 ($124,602); Restricted Stock 11,390 ($248,985); Performance Cash Target $249,000 .

Equity Ownership & Alignment

ItemDetail
Total Beneficial Ownership67,006 Common Shares
Shares in Pension/401k Plan5,055 Common Shares (Pension Plus/401k)
Options – Near-term (≤60 days)41,865 Common Shares subject to acquisition via options vested/vesting within 60 days
Anti-Hedging/PledgingHedging and pledging of company stock prohibited for directors, executive officers, and substantial shareholders
Ownership GuidelinesNo formal executive stock ownership guidelines; management holds significant equity and options

Selected outstanding awards and vesting cadence (as of FY2024 year-end):

  • Restricted Stock: 3,350 vest on 3/1/2025 and 3/1/2027 ; 8,200 vest 50% on 2/22/2026 and 50% on 2/22/2027 .
  • PSUs: 8,200 granted 2/22/2024 (FY2024–FY2026 measurement) .
  • Options: tranches expiring 2025–2033 with staged vesting (e.g., 1,050 vest 3/9/2025; 875 vest 3/8/2025 and 3/8/2026; 13,750 vest 3/7/2025; 6,875 on 3/7/2026 and 3/7/2027) .
  • 2024 activity: no option exercises and no restricted stock vesting for Gramz .

Employment Terms

  • Individual employment, severance, and change-in-control agreements: none; vesting for stock options, restricted stock, and performance cash generally accelerated upon normal retirement or death; Compensation Committee may accelerate upon change-in-control .
  • Retirement: announced retirement effective March 31, 2026, with advisory role planned post-retirement .

Performance & Track Record

Divisional snapshot (Q3 FY2025 – Marcus Theatres):

MetricQ3 FY2025YoY Change
Theatres Revenue ($M)$119.9 -16.6%
Operating Income ($M)$12.3 -$9.4 vs prior year
Adjusted EBITDA ($M)$22.1 -33.4%
Same-store admissions revenuenot disclosed-15.8%
Same-store attendancenot disclosed-18.7%
Avg. ticket pricenot disclosed+3.6%
Concession per personnot disclosed+2.1%

Company performance context:

  • Adjusted EBITDA: $102.4M (2024) vs $108.7M (2023) .
  • Pay-versus-Performance TSR tracker: $100 initial value → $69.80 (MCS) and $132.20 (peer composite) in 2024 .

Gramz’s forward commentary (Q3 FY2025): highlighted an unfavorable film mix in Midwest markets, but cited strong presales for Wicked: For Good and a robust upcoming slate into Q4 and FY2026, pointing to anticipated attendance and revenue recovery .

Compensation Committee & Peer Benchmarking

  • Committee: Allan H. Selig (Chair), Philip L. Milstein, Brian J. Stark; independent directors; met 3x in FY2024 .
  • External consultant: Willis Towers Watson (composite market data; independence assessed; no conflicts) .
  • Pay philosophy: salaries typically targeted at 50th–75th percentile; total cash at 50th–75th percentile; increased at-risk pay for CEO and division presidents (including Gramz) .
  • Long-term incentive metrics benchmark to Russell 2000 percentiles (ROIC and Adjusted EBITDA growth) for PSUs and performance cash .

Say-On-Pay & Shareholder Feedback

  • 2024 meeting (for 2023 NEO pay): over 99% of votes cast and over 97% of all shares entitled voted in favor of NEO compensation .

Compensation Structure Analysis

  • Shift from stock options to PSUs starting FY2024 elevates explicit performance linkage and reduces option-related risk, with approximately 60% of LTI performance-based (PSUs + performance cash) and time-based restricted stock ~40% .
  • Annual incentive structure for Gramz includes division-specific relative metrics (admissions/attendance vs North America) alongside Adjusted EBITDA and contribution margin, reinforcing market-share and profitability focus .
  • Equity grant “burn rate” managed near 1–2% fully diluted; FY2024 ~2.1% and FY2025 YTD ~0.9% (NEO share ~1.7% and ~0.7% respectively) .

Related Party, Legal, and Risk Indicators

  • Hedging/pledging prohibited for executives and substantial shareholders (alignment positive) .
  • No individual executive employment/severance agreements; change-in-control acceleration discretionary (governance mixed—flexibility vs. clarity) .
  • No disclosed legal proceedings involving Gramz; company disclosure indicates no officer/director issues in the last ten years (with CFO prior employer bankruptcy noted separately) .

Equity Ownership & Vesting Pressure Timeline (Selected)

  • Near-term vesting: RS tranches on 3/1/2025; 2/22/2026; 2/22/2027; options tranches vesting on 3/9/2025, 3/8/2025 & 3/8/2026, and 3/7/2025–2027 .
  • Retirement on 3/31/2026 may accelerate certain vesting under plan discretion and standard retirement accelerations (particularly for time-based restricted stock under plan terms), potentially contributing to selling pressure around vest dates .

Investment Implications

  • Strong pay-for-performance alignment: Annual divisional metrics include EBITDA and market-relative growth; LTI tied to ROIC and EBITDA growth vs Russell 2000 with clear percentile payout curves—supportive of capital discipline and operating improvement under Gramz’s purview .
  • Short-term headwinds vs slate: Q3 FY2025 divisional declines reflect film mix rather than structural issues, with management guidance to slate-driven recovery—annual incentive outcomes (108% financial component) indicate balanced calibration and performance recognition .
  • Upcoming vesting and retirement: 2026 retirement could accelerate vesting and create episodic insider selling pressure around vest dates; however, anti-hedging/pledging policies reduce misalignment risk .
  • Governance and shareholder support: High say-on-pay approval and prudent burn-rate management suggest compensation governance stability; shift to PSUs enhances multi-year value creation focus and reduces option overhang risk .